Advertisement

Person › Details
Christopher J. Hollowood (Syncona Partners LLP)
Hollowood, Christopher J. (Wellcome Trust 201511 Partner at Syncona)
![]() |
Organisation | Syncona Partners LLP |
Today | Syncona Ltd. (LON: SYNC) | |
Group | Syncona (Group) | |
Former/major organisation | Freeline Therapeutics Ltd. | |
Group | Freeline Therapeutics (Group) | |
![]() |
Product | venture capital |
Product 2 | LIFE SCIENCES | |
Record changed: 2023-11-27 |
Advertisement

More documents for Christopher J. Hollowood
- [1] Freeline Therapeutics Holdings plc. (11/22/23). "Press Release: Syncona to Acquire Freeline Therapeutics". London....
- [2] Beacon Therapeutics Holdings Ltd.. (6/12/23). "Press Release: Beacon Therapeutics Launches with £96 Million ($120 Million) to Develop a New Generation of Gene Therapies for Retinal Diseases Resulting in Blindness". London & Oxford....
- [3] Syncona Ltd.. (4/5/23). "Press Release: Syncona Appoints Roel Bulthuis as Managing Partner"....
- [4] SwanBio Therapeutics, Inc.. (5/18/22). "Press Release: SwanBio Therapeutics Announces $56 Million Series B Financing to Advance Novel Gene Therapies for Neurological Conditions". Philadeliphia, PA....
- [5] Purespring Therapeutics Ltd.. (7/30/21). "Press Release: Syncona Founds Purespring with a £45m Series A Financing"....
- [6] Freeline Therapeutics Ltd.. (5/4/20). "Press Release: Freeline Receives Orphan Drug Designation from the FDA for FLT190 for the Treatment of Fabry Disease". London....
- [7] Freeline Therapeutics Ltd.. (2/12/20). "Press Release: Freeline Presents Data on Its AAV-based Gene Therapies for Fabry Disease and Gaucher Disease at the 16th annual WORLDSymposium". London....
- [8] Freeline Therapeutics Ltd.. (2/4/20). "Press Release: Freeline Appoints Theresa Heggie as Chief Executive". London....
- [9] Freeline Therapeutics Ltd.. (19/12/19). "Press Release: Syncona Makes a Further $80 Million Commitment to Freeline". London....
- [10] Freeline Therapeutics Ltd.. (6/13/19). "Press Release: Freeline Announces Senior Leadership Transition and Completion of Series B Financing Milestones"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top